These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16712471)

  • 1. Inhibitors of HIV-1 Tat-mediated transactivation.
    Richter SN; Palù G
    Curr Med Chem; 2006; 13(11):1305-15. PubMed ID: 16712471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat.
    Eilebrecht S; Benecke BJ; Benecke AG
    Genomics Proteomics Bioinformatics; 2017 Oct; 15(5):313-323. PubMed ID: 29037489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.
    Sedore SC; Byers SA; Biglione S; Price JP; Maury WJ; Price DH
    Nucleic Acids Res; 2007; 35(13):4347-58. PubMed ID: 17576689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
    Fong YW; Zhou Q
    Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
    Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
    Brès V; Gomes N; Pickle L; Jones KA
    Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional differences between human and bovine immunodeficiency virus Tat transcription factors.
    Bogerd HP; Wiegand HL; Bieniasz PD; Cullen BR
    J Virol; 2000 May; 74(10):4666-71. PubMed ID: 10775603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N; Basu A; Pandey VN
    Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells.
    Fujinaga K; Irwin D; Taube R; Zhang F; Geyer M; Peterlin BM
    J Virol; 2002 Dec; 76(24):12934-9. PubMed ID: 12438619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.